Billions in Global Wound Product Sales, Yet Chronic Wounds Remain a Chronic

Problem, Based on New Research from MedMarket Diligence

Despite the legion of products developed for wound care, from dressings to negative pressure
wound therapy to bioengineered skin and growth factors, the obesity- and age-driven increase in
chronic slow-healing and non-healing wounds plague healthcare systems globally. Research and
routine clinical practice have advanced the science to better understand and address chronic
wounds, but much work remains for research and manufacturing to impact the growing caseload.

Biddeford, ME, April 10, 2018 --(PR.com)-- Chronic wounds represent a large but still underestimated
problem for health systems globally and industry needs to step up in response, according to MedMarket
Diligence, LLC.

"Our recent research shows that chronic wounds, which have long been no secret to clinicians,
epidemiologists, and product manufacturers as a growing health problem, are actually even more
prevalent and costly than has been previously reported," says Patrick Driscoll of MedMarket Diligence,
who has tracked wounds in clinical practice and industry for 25 years.

Care of chronic wounds is a significant, global burden on healthcare systems. In the USA alone, it is
estimated that at least 6.7 million people suffer with chronic wounds, requiring treatment in excess of
$20-50 billion per year (estimates vary according to the definitions). A report from the UK suggests,
based on National Health System (NHS) data, that chronic wound prevalence in developed countries is
about 6% and that care of chronic wounds accounts for around 3-5.5% of total healthcare spending in
those countries. (Phillips CJ, et al. Estimating the costs associated with the management of patients with
chronic wounds using linked routine data. Int Wound J. 2015. doi: 10.1111/iwj.12443.)

Definitions help clinicians determine whether a wound is healing or not. For example, for venous leg
ulcers (VLUs), if the wound has not shown at least a 40% reduction in wound size in about four weeks,
then additional therapies are called for. A non-healing foot ulcer is generally defined to be any ulcer that
is unresponsive to standard therapies and persists after four weeks of standard care. Once a foot ulcer
occurs, unfortunately some 60% of patients end up moving into the chronic non-healing category. Many
diabetics develop foot ulcers.

Chronic wounds and burns continue to present challenging clinical problems. For example, chronic
wounds may present with persistent infections, inflammation, hypoxia, non-responsive cells at the wound
edge, the need for regular debridement, etc. For DFUs, it is important for the patient to continuously wear
an offloading device such as a special boot. Additionally, the practitioner must carefully debride not only
the necrotic tissue in the wound bed, but the wound edges. Cells at the wound edge seem to be
unresponsive to typical healing signals, and therefore must be removed to promote and support proper
healing.

Wound management is the subject ongoing research and publications by MedMarket Diligence, LLC;
https://mediligence.com/s254/.

Page 1/2
PR.com Press Release Distribution Terms of Use
Contact Information:
MedMarket Diligence, LLC
Patrick Driscoll
207-613-6701
Contact via Email
www.mediligence.com

Online Version of Press Release:

You can read the online version of this press release at: https://www.pr.com/press-release/749444

News Image:

Page 2/2
PR.com Press Release Distribution Terms of Use